Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma

Figure 8

Comparison of CD25 FITC and CD127 PE among CD4-positive T cells (Treg cells) before and after chemotherapy. There were no significant differences of Treg cells between before treatment and after treatment in either group, although Treg cells decreased after treatment in both groups.